Jan Marini Skin Research Launches RosaLieve
San Jose, CA (April 6, 2016) - Jan Marini Skin Research, Inc. (JMSR), a leading provider of professional skin care and aesthetic solutions, announced the launch of a unique new formulation - RosaLieve Redness Reducing Complex. This innovative formula that uses azelaic acid, an anti-redness peptide and multiple extracts shown to reduce reactivity including concentrated green tea extract, oat extract and red and white tea extracts. The goal of RosaLieve is to reduce redness and reduce the severity and frequency of flushing.
Jan Marini, CEO of Jan Marini Skin Research states, "Redness is a multi-faceted, complex issue with very few available solutions. RosaLieve is one of the first topical products that truly targets individuals who suffer from facial redness and flushing."
RosaLieve Redness Reducing Complex completes JMSR's portfolio of accelerators designed to address the most significant skin care concerns including pigmentation, wrinkles, dark circles, acne and redness. RosaLieve began shipping on Monday March 28, 2016 and is available through authorized professional JMSR resellers and via the company's website at www.janmarini.com.
About Jan Marini Skin Research, Inc.
A San Jose, CA. based company founded in 1994, Jan Marini Skin Research, Inc. is a recognized leader and innovator in the professionally dispensed skin care market segment. With numerous industry innovations over the past 22 years, including the patented ingredient Thymosin Beta-4 and the first topical lipid-soluble Vitamin C product introduced to the market, JMSR's two primary focuses are to provide innovated technologies that deliver proven measurable results and an unwavering commitment to the ongoing success of our customers.